Skip to the reading

Colorado Peptide care questions

A reader’s edition

Who is responsible when care happens in a clinic?

At a clinic visit, the person explaining a treatment and the person carrying it out may be different people. Ask each person’s role before agreeing to proceed.

Ask everyone’s role, then check which rules apply

Ask who prescribes, who gives the treatment and who follows up. The rules below concern treatments for looks or anti-ageing when a doctor hands work to someone without a health-care licence for that task. Colorado counts those injections as medical work. Under this rule, a doctor cannot hand over prescribing to an unlicensed person.

Unlicensed means the person lacks a health-care licence for that task. These rules concern work handed to such a person. Nurses and physician assistants doing work under their own licences follow other rules.

Colorado added rules on August 6, 2025 requiring notices and patient consent for certain appearance treatments. When a doctor or nurse practitioner hands that work to an unlicensed person, you must get a form explaining this and sign it to show your agreement. Notices must also identify the licensed person responsible. Facilities regulated under the state health-facility law, such as licensed hospitals, are exempt from this act.

Ask the clinic: “Is this an appearance treatment being handed to an unlicensed person? Must you give me that consent form? If you say this facility is exempt, which state health-facility licence or rule covers it?” Read the form before signing. For a shot to treat a health problem, ask which rules apply to that care; the appearance rules above do not answer that question.

Ask what else is part of the offer

If a menu also mentions IV vitamin drips, hormone therapy, lasers or fillers, ask for a separate explanation of each category. Keep the questions about peptide medicine distinct from the rest of the menu.

Selling a product in a medical office can create a conflict over money, Colorado Medical Board guidance says. It calls for board licensees to tell patients about financial deals with the maker or supplier. This is board guidance, not a law.

A useful question is: “Do you have a financial interest in the product or the place supplying it?” Ask how that interest is handled while discussing other options.